CS Medica A/S reported earnings results for the third quarter and nine months ended June 30, 2025. For the third quarter, the company reported negative sales was DKK 0.038898 million compared to sales of DKK 0.453543 million a year ago. Net loss was DKK 1.98 million compared to DKK 3.1 million a year ago. Basic loss per share from continuing operations was DKK 0.1 compared to DKK 0.25 a year ago.
For the nine months, sales was DKK 1.57 million compared to DKK 4.59 million a year ago. Net loss was DKK 7.92 million compared to DKK 8.6 million a year ago. Basic loss per share from continuing operations was DKK 0.42 compared to DKK 0.7 a year ago.